(Q45601006)

14 December 2017

Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera (English)

1 reference

14 December 2017

1 reference

1 reference

3

Thomas W Hennessy

1 reference

14 December 2017

1

Dana L Bruden

1 reference

14 December 2017

10

Lisa R Bulkow

1 reference

14 December 2017

2

Brian J McMahon

1 reference

14 December 2017

5

Chriss E Homan

1 reference

14 December 2017

8

David R Gretch

1 reference

14 December 2017

4

Carol J Christensen

1 reference

14 December 2017

James L Williams

6

1 reference

14 December 2017

Daniel G Sullivan

series ordinal

7

1 reference

14 December 2017

Henry H Cagle

series ordinal

9

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

The American Journal of Gastroenterology

14 December 2017

1 reference

14 December 2017

99

1 reference

14 December 2017

1517-1522

1 reference

14 December 2017

8

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Natural history of chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Syringe exchange and risk of infection with hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30826.X

10.1111/J.1572-0241.2004.30826.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference